XACT Robotics nets CE mark, $5M for its robot-guided needle surgery system

XACT Robotics raised $5 million in venture capital investments alongside a new CE mark for its integrated robotic surgery navigation and steering system for image-guided, needle-puncture procedures, such as ablations and biopsies.

The series C proceeds will help set up and fund seven programs by the end of this year at medical centers in the U.S., Europe and Israel, where the devices will be used. The first launched earlier this year at Hadassah Medical Center in Jerusalem, which participated in a clinical trial evaluating the system’s ability to target lesions.

"The goal of these centers is to gain additional clinical experience and to serve as the primary training centers towards the full product launch of the XACT system planned for 2019," said XACT CEO Chen Levin in a release.

-----------------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.